If you have worked with CapsCanada, you have already worked with Lyfe Group. Our name changed but our team, the products, and quality standards did not.
The rebranding reflects a structural reality that had been building for years: a group of companies operating under a shared manufacturing and distribution ecosystem, now unified under one global identity.
A 40+Year Evolution in Capsule Manufacturing
Lyfe Group’s origins trace back to 1984, when its first gelatin capsules were produced. From the beginning, growth followed the needs of the pharmaceutical and nutraceutical industry, not internal milestones alone.
Key developments shaped that trajectory:
|
1996 |
First modified-release dosage forms, recognizing that delivery performance was becoming as critical as the active ingredient itself. |
|
1999 |
Launch of K-CAPS® HPMC vegetarian capsules, years before plant-based formats became standard in regulated markets. |
|
2001 |
Acquisition of manufacturing facility in Windsor, Ontario, direct control over quality, traceability, and scalability. |
|
2016 |
AR-CAPS® acid-resistant capsules introduced to meet growing demand for precision gastrointestinal and probiotic delivery. |
|
2018 |
$28M investment in a dedicated K-CAPS® facility, increasing production capacity by 50%. |
|
2019 |
Headquarters relocation to Florida and expansion of distribution and manufacturing capabilities across Latin America. |
|
2020 |
During COVID-19, operations continued without interruption. Production volumes increased, and global distribution expanded while other manufacturers faced supply constraints. |
|
2024 |
Launch of K-CAPS® Delayed Release capsules, broadening formulation possibilities for probiotics, enzymes, and other acid-sensitive applications. |
|
2024 |
Expansion of the K-CAPS® Natural Colorants portfolio, supporting growing demand for clean label and naturally colored formulations. |
|
2026 |
CapsCanada rebrands as Lyfe Group |
Why the Shift to Lyfe Group
What was previously recognized as CapsCanada has evolved into a globally integrated manufacturing and supply structure, designed to support pharmaceutical and nutraceutical companies across multiple markets.
Today, Lyfe Group brings together under one unified global brand:
- Empty-Hard capsule manufacturing across North and South America
- Global distribution with consistent product availability
- Capsule supply aligned with both commercial scale and specialized applications
- Technical and regulatory support for pharmaceutical, nutraceutical, and clinical use
Lyfe Group is the name that accurately represents what the organization had become: a global manufacturing platform operating across more than 60 countries, with facilities in Canada and Latin America, and headquarters in the United States.
Leadership Behind the Structure
Jonathan Gilinski, Executive Director of Lyfe Group, has been directly involved in scaling this model across markets and applications.
His work has focused on:
- Capsule formulation and customization
- Manufacturing efficiency and scalability
- Development of specialized solutions such as flavored capsules for improved patient compliance
He is recognized as a subject-matter expert in encapsulation and frequently contributes to industry discussions on manufacturing, compliance, and innovation.
What Lyfe Group Offers Today
The current portfolio covers a broad range of hard capsule formats, all produced under cGMP conditions:
|
Product |
Application |
|
Moisture-sensitive, hygroscopic, or plant-based formulations requiring low water content and non-animal origin |
|
|
Standard oral solid dosage forms with high compatibility across powders, granules, and general formulations |
|
|
Acid-sensitive APIs requiring protection from gastric environment and release in the intestinal tract |
|
|
Formulations requiring pH-dependent release for probiotics and enzymes |
|
|
Low-solubility or high-potency APIs requiring improved bioavailability and content uniformity |
|
|
Early-stage formulations requiring flexibility in composition, color, and regulatory adjustments |
|
|
Capsules for veterinary formulations requiring improved administration and palatability |
|
|
Capsules for formulations requiring taste and odor masking to improve patient compliance, particularly in pediatric or sensitive populations |
Beyond product manufacturing, the group offers technical services including formulation assistance, stability and disintegration testing, regulatory compliance support, and clean label consulting.
The Same Foundation, A Broader Platform
The manufacturing expertise built over four decades continues under the same standards, supported by a broader infrastructure designed for global execution.
Lyfe Group reflects how that experience is now delivered, through integrated manufacturing, consistent supply, and technical alignment with evolving formulation needs.
If your team is evaluating capsule solutions for an upcoming formulation or scaling production, selecting the right manufacturing partner becomes a critical step.
Contact our team to discuss your next capsule project.
